(Q47980556)

English

NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner

scientific article published on 26 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

apoptotic process

1 reference

based on heuristic

inferred from title

Benjamin Krämer

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

Christian Körner

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

author name string

Andreas Glässner

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

Marianne Eisenhardt

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

Martin Coenen

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

Tilman Sauerbruch

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

Ulrich Spengler

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

Jacob Nattermann

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

publication date

26 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

Laboratory Investigation

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

92

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

967-977

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

https://scigraph.springernature.com/pub.10.1038/labinvest.2012.54

0 references

Immunopathogenesis in hepatitis C virus cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Immunobiology and pathogenesis of viral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Hepatitis C virus core and E2 protein expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Amelioration of hepatic fibrosis by NK cell activation.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

CD107a as a functional marker for the identification of natural killer cell activity.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

21 January 2018

Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.54

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LABINVEST.2012.54

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22449797

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47980556&oldid=2179786467"